ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Induction therapy"

  • 2020 American Transplant Congress

    Differences in Immunosuppressive Therapy among Liver Retransplantation Recipients in a National Cohort

    A. K. Mezochow, P. L. Abt, T. Bittermann

    Hospital of the University of Pennsylvania, Philadelphia, PA

    *Purpose: There is no unified consensus as to the preferred immunosuppression (IS) strategy following liver retransplantation (reLT). This study explored: (i) factors associated with induction…
  • 2020 American Transplant Congress

    Effect of Rituximab Dose as Induction Therapy in ABO Incompatible Living Kidney Transplantation A Systemic Review and Network Meta Analysis

    S. Hwang1, W. Park2, K. Kim1, S. Lee1, J. Song1

    1Inha University, Incheon, Korea, Republic of, 2Keimyung University, Daegu, Korea, Republic of

    *Purpose: ABO-incompatible living kidney transplantation (ABOILKT) has steadily become more widespread. However, the optimal immunosuppressive regimen for ABOILKT remains uncertain. We aimed to determine the…
  • 2020 American Transplant Congress

    Clinicopathological Evaluation of Long-Term Survivor More Than 10 Years after Living Kidney Transplant with Corticosteroid Early Withdrawal Protocol

    H. Sasaki1, T. Tanabe1, H. Higuchi1, T. Tsujimoto2, H. Harada1

    1Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan, 2Pharmacy, Sapporo City General Hospital, Sapporo, Japan

    *Purpose: We have previously reported that favorable short-term outcomes of kidney recipients were achieved by corticosteroid early withdrawal protocol (CSEW) compared to the conventional protocol…
  • 2020 American Transplant Congress

    Evaluation of Cytomegalovirus Prophylaxis in Low and Intermediate Risk Kidney Transplant Recipients Receiving Lymphocyte-Depleting Induction

    H. Stamps, K. Linder, D. O'Sullivan, F. Cheema, H. Kutzler

    Hartford Hospital, Hartford, CT

    *Purpose: This study evaluates if choice and duration of Cytomegalovirus (CMV) prophylaxis based on donor (D) and recipient (R) CMV serostatus impacts the incidence of…
  • 2020 American Transplant Congress

    Comparison of Anti-Thymocyte Globulin and Alemtuzumab as Induction Therapy in Older Kidney Transplant Recipients

    M. Chaung, E. Hollinger, M. Brokhof, N. Alvey, L. Lineberger, N. Kenyon

    Rush University Medical Center, Chicago, IL

    *Purpose: The purpose of this study is to evaluate the safety and efficacy of induction with either anti-thymocyte globulin (ATG) (total dose 5 mg/kg) or…
  • 2020 American Transplant Congress

    Low-Dose Rabbit Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients at High Immunologic Risk is Safe and May Prevent Excess Rejection

    E. Sartain1, B. Nettles1, B. Crowther1, P. Klem1, K. Schwarz1, S. Davis2

    1University of Colorado Hospital, Aurora, CO, 2University of Colorado School of Medicine, Aurora, CO

    *Purpose: Patients aged ≥65 years are a growing segment of kidney transplant recipients (KTRs). Consensus on induction immunosuppression in this population is unclear given higher…
  • 2020 American Transplant Congress

    Impact of Alemtuzumab Induction on Cardiac Allograft Vasculopathy in Orthotopic Heart Transplant Recipients

    M. Plazak1, X. Gao2, S. Gale2, B. Reed2, R. Madathil1, S. Hammad1, B. Ravichandran1

    1University of Maryland Medical Center, Baltimore, MD, 2University of Maryland School of Pharmacy, Baltimore, MD

    *Purpose: Cardiac allograft vasculopathy (CAV) is impacted by acute rejection and ultimately limits long-term survival of orthotopic heart transplant (OHT) recipients, thus there is interest…
  • 2020 American Transplant Congress

    Pancreas Transplant in Patients Older Than 50: An Analysis of Outcomes and Immunosuppression

    I. Booth1, J. Casale1, S. Freedman1, B. Ravichandran1, J. Scalea2, A. Haririan2, B. Masters1

    1Pharmacy, University of Maryland Medical Center, Baltimore, MD, 2Medicine, University of Maryland Medical Center, Baltimore, MD

    *Purpose: Pancreas transplant (PT) is the ideal therapy for many patients with diabetes and kidney failure. There are limited published data addressing the impact of…
  • 2020 American Transplant Congress

    Thymoglobulin (ATG) Induction vs. Campath vs. Simulect in DCD Kidneys in UK; Induction Regimes Play a Role after All

    A. Asderakis1, T. Sabbah1, J. Watkins2, L. Szabó1, D. Elker1, A. M. Ilham1, E. Ablorsu1, M. Stephens1, U. Khalid1, R. Chavez1

    1Cardiff Transplant Unit,, University Hospital of Wales, Cardiff, United Kingdom, 2Infection and Immunity, Cardiff University, Cardiff, United Kingdom

    *Purpose: Controlled DCD kidneys have increased dramatically in UK. They suffer from a higher rate of DGF and, often in UK, come from older donors…
  • 2020 American Transplant Congress

    Safety Outcomes in Lower-Weight vs Higher-Weight Recipients of Fixed Dose Alemtuzumab for Kidney Transplant Induction

    A. Freeman, S. Anders, B. Wise, M. Janusek, L. Hutchinson, U. Kaszubski, D. Marroquin, D. Martin, H. Bohorquez

    Ochsner Medical Center, New Orleans, LA

    *Purpose: Alemtuzumab is a lymphocyte-depleting monoclonal antibody used for renal transplant induction, and is associated with significant leukopenia, increased infections and malignancy. Multiple dosing strategies…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 31
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences